Is PHAS or O a better dividend investment in 2026?

PHAS currently yields 2853.07% with a 5% 5-year dividend growth rate. O yields 5.28% with 3.2% growth. The better choice depends on your goal: PHAS offers higher current income.

What is the dividend yield difference between PHAS and O?

PHAS has a forward dividend yield of 2853.07% ($2.00/share annually). O yields 5.28% ($3.23/share annually). The yield gap is 2847.79 percentage points.

Home › Compare › PHAS vs O

PHAS vs O: Dividend Comparison 2026

PHAS yields 2853.07% · O yields 5.28%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 PHAS wins by $281872346867.00M in total portfolio value

INVESTMENT

TIME HORIZON10 years

PHAS

● Live price

2853.07%

Share price

$0.07

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$281872346867.04M

Annual income

$263,691,193,706,389,300.00

Full PHAS calculator →

Realty Income Corporation

● Live price

5.28%

Share price

$61.15

Annual div

$3.23

5Y div CAGR

15.1%

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$34.2K

Annual income

$5,102.74

Full O calculator →

Portfolio growth — PHAS vs O

📍 PHAS pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	PHAS	O
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, PHAS + O cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

PHAS pays

O pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

PHAS

Annual income on $10K today (after 15% tax)

$242,510.70/yr

After 10yr DRIP, annual income (after tax)

$224,137,514,650,430,900.00/yr

Annual income on $10K today (after 15% tax)

$449.12/yr

After 10yr DRIP, annual income (after tax)

$4,337.33/yr

At 15% tax rate, PHAS beats the other by $224,137,514,650,426,560.00/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of PHAS + O for your $10,000?

PHAS: 50%O: 50%

100% O50/50100% PHAS

Portfolio after 10yr

$140936173433.54M

Annual income

$131,845,596,853,197,200.00/yr

Blended yield

93.55%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on O right now

PHAS

Analyst Ratings

Buy

Hold

Consensus: Buy

Analyst Ratings

Buy

Hold

Sell

Consensus: Hold

Price Target

$64.00

+4.7% upside vs current

Range: $60.00 — $69.00

Altman Z

1.0

Piotroski

5/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

PHAS buys

O buys

No recent congressional trades found for PHAS or O in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricPHASO

Forward yield	2853.07% ✓	5.28%
Annual dividend / share	$2.00	$3.23 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	15.1% ✓
Portfolio after 10y	$281872346867.04M ✓	$34.2K
Annual income after 10y	$263,691,193,706,389,300.00 ✓	$5,102.74
Total dividends collected	$280611873155.80M ✓	$20.7K
Payment frequency	quarterly	monthly
Sector	Stock	REIT
Analyst consensus	Buy	Hold

Year-by-year: PHAS vs O ($10,000, DRIP)

Year	PHAS Portfolio	PHAS Income/yr	O Portfolio	O Income/yr	Gap
1← crossover	$296,007	$285,306.70	$10,818	$608.16	+$285.2K → PHAS
2	$8,209,503	$7,892,775.47	$11,787	$741.68	+$8.20M → PHAS
3	$213,363,270	$204,579,102.60	$12,946	$911.00	+$213.35M → PHAS
4	$5,197,428,076	$4,969,129,376.72	$14,345	$1,127.94	+$5197.41M → PHAS
5	$118,688,009,645	$113,126,761,603.35	$16,056	$1,409.05	+$118687.99M → PHAS
6	$2,541,344,545,416	$2,414,348,375,096.37	$18,171	$1,777.83	+$2541344.53M → PHAS
7	$51,033,223,710,004	$48,313,985,046,408.66	$20,820	$2,268.21	+$51033223.69M → PHAS
8	$961,336,701,807,468	$906,731,152,437,763.20	$24,188	$2,929.90	+$961336701.78M → PHAS
9	$16,991,731,925,840,448	$15,963,101,654,906,456.00	$28,533	$3,837.11	+$16991731925.81M → PHAS
10	$281,872,346,867,038,600	$263,691,193,706,389,300.00	$34,235	$5,102.74	+$281872346867.00M → PHAS

PHAS vs O: Complete Analysis 2026

PHAS — Stock

PhaseBio Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel for cardiovascular diseases. Its lead product candidate is bentracimab (PB2452), a reversal agent for the antiplatelet drug ticagrelor that is in Phase III clinical trial for patients with uncontrolled major or life-threatening bleeding events or in patients requiring urgent or an invasive procedure. The company is also developing PB1046, a vasoactive intestinal peptide analogue for the treatment of pulmonary arterial hypertension; and PB6440 for the treatment of resistant hypertension. The company has a co-development agreement with SFJ Pharmaceuticals X, Ltd. to develop PB2452, a reversal agent for the antiplatelet drug ticagrelor. PhaseBio Pharmaceuticals, Inc. was incorporated in 2002 and is based in Malvern, Pennsylvania. On October 23, 2022, PhaseBio Pharmaceuticals, Inc. filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware.

Full PHAS Calculator →

O — REIT

Realty Income, The Monthly Dividend Company, is an S&P 500 company dedicated to providing stockholders with dependable monthly income. The company is structured as a REIT, and its monthly dividends are supported by the cash flow from over 6,500 real estate properties owned under long-term lease agreements with our commercial clients. To date, the company has declared 608 consecutive common stock monthly dividends throughout its 52-year operating history and increased the dividend 109 times since Realty Income's public listing in 1994 (NYSE: O). The company is a member of the S&P 500 Dividend Aristocrats index. Additional information about the company can be obtained from the corporate website at www.realtyincome.com.

Full O Calculator →

📬

Get this PHAS vs O comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

PHAS vs SCHD PHAS vs JEPI PHAS vs KO PHAS vs MAIN PHAS vs STAG PHAS vs ADC PHAS vs NNN PHAS vs VICI

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.